New research from the University of Sydney reveals surgically implanted spinal cord stimulators—a common treatment for lower back pain which aims to disrupt pain signals traveling to the brain—are costly and putting patients at risk of needing ongoing surgical interventions to fix complications, with a quarter receiving the treatment going on to require corrective surgery.